Caricamento...
Long-term outcomes in patients aged 70 years or less with intravenous glyburide from the phase II GAMES-RP study of large hemispheric infarction: an exploratory analysis.
BACKGROUND AND PURPOSE: We aimed to determine whether subjects aged ≤70 years who were treated with intravenous glyburide (RP-1127; BIIB093; glibenclamide) would have better long-term outcomes than those who received placebo. METHODS: Glyburide Advantage in Malignant Edema and Stroke-Remedy Pharmace...
Salvato in:
| Pubblicato in: | Stroke |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6192530/ https://ncbi.nlm.nih.gov/pubmed/29789393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.117.020365 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|